TARS
TARS
NASDAQ · Pharmaceuticals

Tarsus Pharmaceuticals Inc

Mid-Cap Stocks Pharmaceutical Stocks Healthcare Stocks
$78.09
-0.94 (-1.19%)
As of Sep 21, 1:26 PM ET ·
Analyst Consensus
Strong Buy
14
Analysts
Moderate
Coverage
Buy 13 93%
Hold 1 7%
Sell 0 0%
Price Target
Analyst Price Target +4.4% upside
Low Target $66.63
Average Target $81.52
High Target $107.19
Current Price $78.09
Current
$78.09
Target
$81.52
$66.63 $81.52 avg $107.19
Scenario Analysis
Bear Case
$66.63
-14.7%
Low target
Base Case
$81.52
+4.4%
Avg target
Bull Case
$107.19
+37.3%
High target
Risk/Reward
2.5x
Favorable
Price in Context
52-Week High
$91.53
-14.7% from high
52-Week Low
$50.71
+54.0% from low
50-Day SMA
$73.37
+6.4% vs SMA
200-Day SMA
$59.46
+31.3% vs SMA
RSI (14)
49.6
Neutral
Target vs 52W High
$81.52
-10.9% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
 Strong Buy 38 79% $1,330.33 +14.0%
RDY
Dr. Reddy's Laboratories
 Strong Sell 45 31% — +0.0%
JNJ
Johnson & Johnson
 Buy 31 71% $299.55 +10.5%
MRK
Merck & Co. Inc.
 Buy 36 72% $159.27 +6.1%
PFE
Pfizer Inc.
 Hold 36 39% $33.90 +21.5%
BMY
Bristol-Myers Squibb Co
 Hold 35 43% $174.50 +177.1%
RPRX
Royalty Pharma Plc- Cl A
 Strong Buy 16 88% $36.26 -37.9%
ZTS
Zoetis Inc
 Hold 24 50% $209.87 +192.3%